Cultivating Growth Through Research
Our Research and Collaborations
The Now Corporation, a Cannabidiol Biopharmaceutical Research company, is dedicated to advancing the study of the medicinal use of Cannabidiol and other cannabinoids. The Now Corporation seeks to develop Cannabis-derived therapeutic products backed by scientific research.
The Now Corporation, a Cannabinoid Biopharmaceutical Research company, is dedicated to advancing the study of the medicinal use of Cannabidiol (CBD) and other cannabinoid molecules. The Now Corporation seeks to develop cannabis-derived therapeutic products backed by strict and ethical scientific research.
The Now Corporation has developed, and will continue to form relationships, with world class research universities and institutions within the United States to perform collaborative CBD research. Our commitment to further understanding the effects of cannabinoids upon psychiatric-related behavioral characteristics, cardiovascular physiology as well as digestive and metabolic systems will provide unprecedented insight in to the effects of these naturally occurring substances upon human health and disease.
In an effort to uncover the potential therapeutic capacity of cannabinoids, The Now Corporation looks to establish the safest and most effective route of administration of highly purified CBD which currently remains to be determined within scientific literature. Our ability to grow and analyze hemp seed genetic variability, the source of CBD, and its relationship to potency, will aid the pursuit of effective dosing that will be required for maximal health benefits.
The 2018 Farm Bill, which includes language that legalizes hemp across the U.S. provides farmers in a struggling agricultural sector with very profitable alternatives. According to New Frontier Data: China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ($1.0 billion), Europe ($980 million) and South and Central America ($220 million). The U.S. market is positioned to grow under the 2018 Farm Bill, with an estimated $2.6 billion projected in sales by 2022, with $1.3 billion in sales estimated for hemp-derived CBD products by 2022.
The Now Corporation will continue to expand the ways in which hemp is utilized in industrial applications with crops grown from the State of North Dakota, under the Industrial Hemp Program.
The industrial hemp products being investigated include:
- Bio-fuel derived from seeds
- Hemp stalk/leaves for fiber material
- Hemp root for medicinal purposes
Hemp Plant Biology
The Now Corporation has established a joint venture in the Commonwealth of Puerto Rico with the goal of understanding and improving hemp plant biology. Using a scientific approach, we seek to research and produce hemp seeds with superior genetic characteristics, cultivated in an environmentally controlled greenhouse with filtered water and optimum nutrients.